Keywords：方药研究, 实验研究, 配方资产, 转化沟通, 3.3.6 中药抑制肝癌血管的生成
Section Index
3.1 Changes and Analysis of Clinical Symptoms and Signs Before and After Treatment
·296·
Table 3 Changes in Symptoms and Signs Before and After Treatment
| Treatment Group | Control Group | |||||||
|---|---|---|---|---|---|---|---|---|
| Number of Cases | Time to Disappearance | Number of Disappearances | Disappearance Rate | Number of Cases | Time to Disappearance | Number of Disappearances | Disappearance Rate | |
| Infection | 10 | 16±1.78 | 8 | 80% | 10 | 21±2.86 | 6 | 60.7% |
| Anemia | 14 | 17±3.81 | 12 | 85.7% | 13 | 22±4.97 | 7 | 53.8% |
| Bleeding | 6 | 9±2.35 | 5 | 83.3% | 5 | 13±2.43 | 3 | 60% |
| Leukemia Cell Infiltration |
According to t-test (P<0.05), the time to disappearance in the treatment group was significantly shorter than that in the control group. Combined traditional Chinese and Western medicine treatment for CML can effectively improve patients' clinical symptoms such as infection, anemia, and bleeding in the short term, thereby improving their quality of life. The disappearance rate, as determined by χ² test (P<0.05), was also significantly higher in the treatment group than in the control group. This indicates that Pei's "Lanzhou Formula" can markedly reduce the toxic side effects of hydroxyurea, improve patients' hematopoietic function, and effectively control adverse clinical reactions.
This chapter is prepared for online research and reading; for external materials, please align with original publications and the review process.